Previous studies have demonstrated that Ara-ATP can inhibit poly(A) polymerase activity by competing with ATP. To elucidate the mechanism of action of this compound, its effect on the cleavage and polyadenylation of two specific substrates, SV40L and adenovirus L3 pre-mRNAs, was studied in HeLa nuclear extracts. Unlike cordycepin 5' triphosphate, Ara-ATP inhibited both cleavage and poly(A) addition. Addition of poly(A) polymerase fraction devoid of any other factors required for the processing reactions overcame the inhibitory effect on cleavage as well as polyadenylation of pre-mRNAs. These data suggest that Ara-ATP inhibits both cleavage and polyadenylation reactions by interacting with the ATPbinding site on poly(A) polymerase, the activity of which is essential for the cleavage reaction. Ara-ATP also blocked formation of the post-cleavage and polyadenylation-specific complexes, which further confirmed the inhibitory effect of the ATP analog on the two tightly coupled 3'-end processing reactions.
INTRODUCTION
The 3'-end processing of pre-mRNA substrates is a complex multistep reaction involving several protein components (1) (2) (3) . The advent of in vitro polyadenylation system (4) which mimics the in vivo 3'-end processing with remarkable accuracy has facilitated elucidation of the mechanism of this complex process. The pre-mRNA substrate is first cleaved endonucleolytically at an adenosine residue to which 200 -250 AMP residues are added.
Both cleavage and polyadenylation reactions are tightly coupled and require the highly conserved hexamer sequence (AAUAAA) found 10-30 nucleotides upstream of the poly(A) site. GU or U rich elements present downstream of the cleavage site are critical but not absolutely necessary for cleavage reaction (5) . The cleavage reaction can be uncoupled from polyadenylation in vitro by using either ATP analogs, [3' dATP or AMP(CH2)PP] or EDTA. Similarly, polyadenylation reaction can be studied independent of the initial cleavage by using premRNA substrates whose 3'-end is the actual or very near to the poly(A) site. Until now, no inhibitor of the cleavage reaction has been reported. A few years ago, we reported that Ara-ATP (9-3-D-arabinofuranosyladenine triphosphate) derived from Ara-A, a potent antiviral agent, is an inhibitor of poly(A) synthesis in vitro (6) . A unique observation has been the selective inhibition of poly(A) synthesis without affecting RNA synthesis (6) which was in marked contrast to that observed for cordycepin 5' triphosphate (7) . Nevertheless, both ATP analogs could inhibit the poly(A) synthesis in vitro at relatively low concentrations which were not inhibitory to RNA synthesis (6, 8) . As observed for cordycepin 5' triphosphate (8) , the sensitivity to Ara-ATP of the initial polyadenylation reaction associated with the chromatin was significantly greater than the chain elongation reaction (6) . Although these studies did not utilize specific premiRNA substrates, there was a remarkable similarity of the inhibitory characteristics of these compounds to those observed in vivo (see Discussion). The availability of the cell-free systems to study the 3'-end processing of mRNAs prompted us to examine the effect of Ara-ATP on these reactions using SV40 late and adenovirus L3 pre-mRNAs as the substrates. The present studies report the results of such an investigation. Preparation of HeLa cell nuclear extract and its fractionation HeLa nuclear extracts were prepared essentially by the method of Dignam et al. (11) with the following modifications: PMSF was omitted from all the buffers, the crude nuclear pellet was resuspended in 0.7 ml buffer C/ml packed cell volume and the final dialysate was centrifuged for 5 minutes at 5,000 rpm in a microfuge.
MATERIALS AND METHODS
The 20-40% fraction of HeLa nuclear extract was prepared according to Takagaki, Ryner and Manley (12) . This fraction was then dialyzed in HG20MEDAS [20 Gel shift analysis of in vitro polyadenylation reaction products Polyadenylation reactions were carried out in presence of ATP or Ara-ATP as described earlier. To study the nature of RNAprotein complexes formed the reactions were stopped by adding heparin (5 mg/ml, final concentration) and the products were analyzed in non-denaturing polyacrylamide gel (4% acrylamide, PRE]m. RESULTS AND DISCUSSION Ara-ATP inhibits polyadenylation of SV40 L and Adeno L3 pre-mRNA substrates When 32P-labelled SV40L pre-mRNA substrate (-58/+55) was incubated with HeLa nuclear extract in presence of 1 mM ATP and other co-factors, it was efficiently polyadenylated (Fig. 1,  lane 1) . When Ara-ATP was added to this reaction mixture in increasing amounts, polyadenylation of the substrates was proportionately decreased (Fig. 1, lanes 2-6) . Significant inhibition of polyadenylation was observed at 0.25 mM Ara-ATP (Fig. 1, lane 2) . Polyadenylation was completely blocked at 2 mM Ara-ATP (Fig. 1, lane 5) . Concomitant with inhibition of poly(A) addition, accumulation of unprocessed substrate molecules but not of the cleaved product (70 nucleotides) was observed (Fig. 1, lanes 2-6) . Similar result was obtained when adeno L3 pre-mRNA was used as the substrate (Fig. 2) . In presence of ATP, adeno L3 pre-mRNA was efficiently polyadenylated (Fig. 2 , lane 2) in HeLa nuclear extract. When ATP was replaced by 3' dATP, the cleaved RNA of 147 nucleotide was accumulated (Fig. 2, lane 6) . But neither the cleaved nor the polyadenylated RNA was formed when Ara-ATP was added in increasing amounts to the reaction mixture (Fig. 2,  lanes 3-5) . Even at a concentration of 1 mM, Ara-ATP completely impaired the 3'-end processing of adeno L3 premRNA (Fig. 2, lane 3 ). These data demonstrate that Ara-ATP can inhibit polyadenylation of pre-mRNAs and suggest that it may also block the cleavage reaction at the poly(A) site, as no cleaved product was accumulated following inhibition of polyadenylation. Ara-ATP also inhibits the cleavage reaction To confirm further the inhibitory effect of Ara-ATP on the cleavage of pre-mRNA, cordycepin triphosphate (3' dATP) which blocks poly(A) chain elongation without interfering the cleavage reaction was used to detect the cleaved product. When polyadenylation was blocked by 3'dATP, the cleaved product was accumulated (Fig. 3, lane 1) . Varying amounts of Ara-ATP were used in the presence of 3' dATP to study the effect of the ATP analog on the cleavage reaction (Fig. 3, lanes 2-4) . Inhibition of the cleavage of SV40L pre-mRNA was evident at 0.5 mM Ara-ATP; complete inhibition was achieved at 2 mM Ara-ATP. The extent of inhibition at concentrations below 2 mM Ara-ATP was not at the same level as that observed for polyadenylation. For example, at 0.5 mM Ara-ATP, polyadenylation was inhibited as much as 85 % (Fig. 1, lane 2 necessary for cleavage are absent in this substrate. This 'precleaved' substrate was efficiently polyadenylated in HeLa nuclear extract (Fig. 4, lane 1) . Ara-ATP inhibited poly(A) addition in a dose-dependent manner (Fig. 4, lanes 2-4) . Complete inhibition of polyadenylation of 'full-length' and 'pre-cleaved' mRNA substrates was achieved at the same (2 mM) concentrations of Ara-ATP (Fig. 1, lane 5 and Fig. 4, lane 4 , respectively). Interestingly, this analog can also inhibit Mn+2-dependent polyadenylation of pre-mRNAs (data not shown), which is usually independent of cleavage (14) .
Ara-ATP inhibits cleavage and polyadenylation reactions by interacting with poly(A) polymerase Unlike cordycepin triphosphate (3' dATP), which selectively inhibits the initial polyadenylation reaction (8) (Fig. 5A, lane 6) . By adding the poly(A) polymerase fraction to HeLa nuclear extract, the inhibitory effect of Ara-ATP on polyadenylation was partly overcome (Fig. 5A, lane 3 vs. lane 4) . Similarly, the effect of Ara-ATP on cleavage was partially reverted by supplementing with poly(A) polymerase fraction (Fig. SB, lane 3 vs. lane 4) . Poly(A) polymerase fraction alone could not catalyze cleavage reaction (Fig. SB, lane 5) unless supplemented with cleavagespecificity fraction (Fig. SB, lane 6 ). These data indicate that poly(A) polymerase is at least one of the factors mediating inhibitory activity of Ara-ATP.
Ara-ATP inhibits formation of post-cleavage and polyadenylation specific complexes Studies from several laboratories have shown that the cleavage and polyadenylation of pre-mRNA substrates are mediated by specific RNA-protein complexes (16) (17) (18) (19) . Immediately after addition of RNA to the nuclear extract, a 'non-specific' complex A migrating much slower than free RNA is formed. This complex is non-specific, as it is formed with any RNA (18) . A new complex B or 'pre-cleavage' complex is formed with increase in incubation time. As cleavage proceeds, this slower moving 'pre-cleavage' complex disappears with concomitant appearancê^. .?n_b so_ of the faster migrating 'post-cleavage' complex, B' (18) . When cleaved RNA is polyadenylated after longer period of incubation, the 'polyadenylation-specific complex' pA, migrating faster than B and B', is formed (19) . To investigate whether Ara-ATP inhibits formation of these specific complexes, SV40L 'fulllength' pre-mRNA was incubated with HeLa nuclear extract in presence of ATP (1mM) or inhibitory concentration (2mM) of Ara-ATP for different periods of time. At 0 time, the major complex formed was non-specific (A) with a minor amount of pre-cleavage complex (B) (Fig. 6, lane 2) . At 30 minutes, both pre-cleavage (B) and post-cleavage (B') complexes were formed in the presence of ATP (Fig. 6, lane 3) , whereas only precleavage complex (B) could be detected in the reaction mixture containing Ara-ATP (Fig. 6, lane 4) . At 90 minutes, polyadenylation-specific complex (pA) was formed in ATPcontaining reaction but not in Ara-ATP-containing reaction (Fig. 6 , lane 5 vs. lane 6). Inhibition of specific complex formation by Ara-ATP further proves that this analog is an inhibitor of both cleavage and polyadenylation. Although previous studies have implicated DNA synthesis as the primary site of action of Ara-A (20, 21), two observations suggest alternate mechanism of action for this compound. First, the inhibitory effects of Ara-A cannot be reverted by deoxyadenosine, but rather by adenosine (22, 23) . Second, the adenosine analog can be incorporated into both RNA and DNA (24) , which suggests involvement of this compound at some step in RNA synthesis. Further, the relative lack of inhibition of de novo RNA synthesis by Ara-A (25) indicates that it affects a posttranscriptional reaction(s) which exclusively utilizes ATP. The present studies have clearly shown that an alternate mechanism of action of Ara-A is via inhibition of cleavage and polyadenylation of pre-mRNAs. Although cordycepin and its nucleotide can inhibit the 3'-end processing reaction in vivo, there are a few important differences between this analog and Ara-A and its nucleotide with respect to their mechanisms of action.
First, Ara-A or its nucleotide does not inhibit RNA synthesis in vivo (25) or in vitro (6) , whereas cordycepin or its nucleotide could inhibit RNA synthesis in vivo (26) or in vitro (8) at higher concentrations. Second, cordycepin triphosphate inhibits initial polyadenylation reaction by preventing chain elongation (6) . Ara-ATP inhibits the initial polyadenylation in vitro by competing with ATP and is not a chain terminator by virtue of the availability of free 3'OH group. Third, cordycepin triphosphate inhibits only the poly(A) addition without affecting the cleavage reaction whereas Ara-ATP inhibits both reactions. In fact, Ara-ATP is the only compound which can inhibit both reactions involved in the 3'-end processing of pre-mRNAs. The present study has not only revealed the exact mechanism of action of Ara-A on the 3'-end processing reaction, but also has provided a useful tool to block cleavage and poly(A) addition.
Although one would like to see restoration of cleavage with purified poly(A) polymerase, extensive purification of this enzyme prevents its ability to function in a reconstitution assay. It appears that such elaborate processing of the enzyme (fractionations on at least 8 different columns) destroys its complete functional integrity probably due to partial degradation of poly(A) polymerase, but retains its non-specific activity in a filter binding assay (K. Chrislip and S. Jacob, unpublished data). Although highly purified calf thymus enzyme has been shown to direct hexamer-dependent polyadenylation of pre-cleaved communication). In the absence of a reconstitution assay, the present data at least suggest a direct role of poly(A) polymerase in inhibition of the cleavage reaction by Ara-ATP.
